Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer

Clinical Trial ID NCT00417274

PubWeight™ 1.68‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00417274

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors. Proc Natl Acad Sci U S A 2005 2.14
2 Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers. Cell Commun Signal 2011 0.99
3 Drug discovery in advanced prostate cancer: translating biology into therapy. Nat Rev Drug Discov 2016 0.78
Next 100